Novo Nordisk is lowering the cash price of its weight-loss drug Wegovy and diabetes treatment Ozempic.

• 💸 Why it matters: Novo is fighting to scratch back crucial U.S. market share recently lost to rival Eli Lilly in GLP-1s.

Zoom in: Novo — whose Ozempic has become a shorthand descriptor for weight-loss drugs for many Americans — is lowering the new standard monthly cash price of its two GLP-1 shots from $499 to $349.

• The company this morning unveiled the new price through its own platforms after agreeing earlier this month to offer the reduced pricing on the White House's coming TrumpRx.
• Novo also announced an introductory offer of $199 per month — providing two months of treatment — for self-pay patients through March 31.
• The highest dose of Ozempic will remain at $499 per month.

The big picture: The move comes less than two weeks after the Trump administration announced a deal with Novo and its rival Eli Lilly for Medicare to cover weight-loss drugs — a deal that also came with price cuts.

Investors largely shrugged at today's news — Novo shares closed up 0.4%, while Lilly lost just 0.3%.

Go deeper

Ford Motor is the latest carmaker to try selling cars on Amazon, Axios' Joann Muller writes.

• 💻 The retail giant will let Ford's franchised dealers sell certified preowned vehicles on its site, Ford announced today.
• 🔑 Customers will be able to secure financing, start paperwork and schedule a pickup time for their car.

Zoom out: Hyundai was the first carmaker to list dealer inventory on Amazon back in December 2024, but the program has been slow to take off.

• Amazon also partnered with car rental company Hertz in August to sell used vehicles through its site.

📍 What we're watching: In the case of Ford, about 20 dealers in Los Angeles, Seattle and Dallas have listed used cars for sale. The automaker has 2,900 dealerships nationwide.

The bottom line: The auto industry has been trying to crack online car sales for decades, but strong dealer franchise laws and entrenched consumer behavior have limited their efforts.

Stay ahead on trends upending the auto industry with Joann's Axios Future of Mobility newsletter.

🪐 Jeff Bezos is poised to become co-chief executive of a new AI startup called Project Prometheus. The company, which he also invested in, is focusing on technology that will enable the Amazon founder's pursuit of space travel. (NYT)

📈 Alphabet shares rose 3% after Berkshire Hathaway disclosed a stake in the company. The investment in Google's parent company marks one of the final major deals for Berkshire under Warren Buffett's leadership. (CNBC)

💊 Johnson & Johnson agreed to acquire Halda Therapeutics for $3.05 billion. Halda is pursuing various cancer treatments, including an oral treatment for prostate cancer. (Reuters)

Nike is dashing to turn around its running shoe division amid a prolonged slowdown — and one big reason is that competitors have had success with heftier kicks.

State of play: "A decade ago, the fastest sneakers were minimalistic, slamming against the ground with each stride to spur peak performance," Bloomberg reports.

• "Since then, they've ballooned in size and cushioning as designers added layers of squishy superfoams and airbags to make them more comfortable while retaining speed."

👟 Zoom in: The shift toward a "chunky" design is best seen in competitors like Hoka's "engorged Bondi sneakers" and On's "honeycombed Cloudmonster shoes," Bloomberg noted.

• The latter, for example, includes features such as carbon speedboards and energy-returning foams.

💭 Nathan's thought bubble: I was recently dismayed to learn that there are few laceless running shoe options. Life is too short to spend tying shoelaces.